Pfizer, Sandoz Agree to End Caduet Patent Fight

A Delaware federal judge dismissed consolidated patent litigation between Pfizer and Sandoz over Pfizer’s blood pressure and cholesterol drug Caduet, after they agreed to drop the dispute.
Law360